Abstract
In this study, Bernier et al. report on the off-label use of disulfiram to combat diet-induced obesity in mice through normalization of body weight and improvement of various physiological outcomes related to body composition and insulin responsiveness.
| Original language | English |
|---|---|
| Pages (from-to) | 203-214.e4 |
| Journal | Cell Metabolism |
| Volume | 32 |
| Issue number | 2 |
| DOIs | |
| State | Published - 4 Aug 2020 |
Bibliographical note
Publisher Copyright:© 2020
Keywords
- beta-cell hyperplasia
- fibrosis
- hepatic steatosis
- inflammation
- insulin resistance
- obesity
- weight gain